Blinklab is a health information services business based in Australia. Blinklab shares (BB1) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Blinklab has a market cap (total outstanding shares value) of $25.3 million. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Blinklab, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose or you can see our list of the best share trading platforms in Australia. Then follow these steps.
Our top pick for
Best for day trading
Our top pick for
Education & learning
Our top pick for
Low commission
| 52-week range | $0.215 - $0.41 |
|---|---|
| 50-day moving average | $0.3076 |
| 200-day moving average | $0.3043 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | $25.3 million |
TTM: trailing 12 months
We're not expecting Blinklab to pay a dividend over the next 12 months.
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. The company's smartphone-based application serves as a medical device to perform neurometric tests, such as eyeblink conditioning, prepulse inhibition of acoustic startle, and habituation of eye blink response that serve as biomarkers for neurological and psychiatric disorders. Its application records and uploads the neurometric test results to an online platform, where the data is analyzed using machine learning to aid in the diagnosis of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. The company was incorporated in 2021 and is based in Sydney, Australia.
We used Finder's proprietary algorithm to find the 10 best stocks under $10 on the ASX.
We used Finder's proprietary algorithm to find Australian-listed companies that have strong fundamentals and have a share price under $5.
Here are our algorithm-selected 20 Aussie stocks worth watching in 2024.
You can't access Robinhood in Australia, so here are 6 low-cost alternatives to trade US stocks.
Find out the different ways you can invest in the S&P 500 index from Australia.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
A beginner's guide to options trading in Australia. Read the step-by-step process and compare brokers to start trading.
If you're looking to start your investment journey, here's how to open a share trading account.
Compare share trading apps to find out which app has all the tools and resources you need to reach your investment goals.
Follow these tips to find the best share trading platform for you.